Scirpus: A Comprehensive Encyclopedic Reference
1. Identity, Taxonomy, and Botanical Description
Genus and Nomenclature
Scirpus is a genus of grass-like species in the sedge family Cyperaceae, many carrying the common names club-rush, wood club-rush, or bulrush. The name derives from the classical Latin scirpus, a term used by Roman authors for rush-like wetland plants. As a dietary supplement and traditional medicinal ingredient, multiple species within the genus — and in closely allied genera — are used, most notably Scirpus yagara Ohwi, Scirpus fluviatilis (Torr.) A. Gray, Scirpus grossus L.f., Scirpus lacustris L., Scirpus maritimus L., Scirpus articulatus L., and Scirpus holoschoenus L.
Taxonomic Complexity and Related Genera
The taxonomy of the genus is complex and under review by botanists. Recent studies by taxonomists of the Cyperaceae have resulted in the creation of several new genera, including Schoenoplectus and Bolboschoenus; others, including Blysmus, Isolepis, Nomochloa, and Scirpoides, have also been used. As a result, species historically assigned to Scirpus and discussed in the medical literature — including Scirpus lacustris, now Schoenoplectus lacustris, and Scirpus holoschoenus, now Scirpoides holoschoenus — are frequently referenced under their older synonyms in pharmacological and ethnobotanical literature. In the supplement and traditional medicine context, the name "Scirpus" is broadly used to encompass this entire complex of related sedge species.
Morphological Characteristics
Scirpus species are rhizomatous perennial herbs with three-angled stems and flat, grass-like leaves. The flowers are arranged in clusters of small spikelets, often brown or greenish-brown in color. Some species, such as S. lacustris, can reach a height of 3 metres (10 feet), while S. sylvaticus is about 1.2 m (4 ft) and others, such as S. supinus, are much smaller, reaching only 20–30 centimetres (8–12 in) tall.
They mostly inhabit wetlands and damp locations. Scirpus yagara Ohwi is a perennial Cyperaceae species growing in ponds and swamps. Bulrushes are erect, perennial, grass-like plants with one three-sided stem that can grow up to 3 meters (9 ft) tall and have leaves between 4 and 6 mm wide.
Common Names and Synonyms
The genus encompasses a wide range of common names across languages and cultures:
- English: Bulrush, club-rush, bur-reed, tule (from Nahuatl), wool grass, rat grass, river bulrush (for S. fluviatilis), seaside bulrush (for S. maritimus)
- Chinese: San Leng (三棱), Da piao cao
- Sanskrit/Ayurvedic: Kaseruka, Kaseru, Kasheruka, Gundakanda, Rajakaseruka
- Hindi: Kaseru
- Japanese: Yagara (for S. yagara)
Scirpus holoschoenus L. (family Cyperaceae) is a rare, salty-marsh, perennial, approximately 1 meter high grass-like herb. Morphologically, it can be easily confused with Juncus (rush; family Juncaceae) because it is devoid of the characteristic solid three-angled stem of Scirpus, having instead a hollow cylindrical stem.
Plant Parts Used
The plant's rhizomes are harvested in the autumn and winter, dried in the sun, and used in a variety of herbal remedies. The plant's rhizomes are particularly valued for their medicinal and nutritional benefits. Additionally, the root can be eaten raw or cooked and is rich in starch; it can be dried and ground into a powder or made into a syrup. Young shoots can be consumed raw or cooked, and the seed can be ground into a powder and mixed with flour for use in making cakes.
2. Common Forms and Preparations
The recommended preparation of Scirpus in the traditional Chinese medicine context is 3–9 grams of the dried rhizome, placed in boiling water and drunk as a decoction. Dried slices of Scirpus rhizome are available at Asian markets and specialty stores. Scirpus extracts and powders are also commercially available.
As a supplement, Scirpus is encountered in the following forms:
- Dried rhizome slices: The traditional form; sun-dried and stored for decoction.
- Powdered rhizome: Ground dried rhizome used in capsules, tablets, or mixed with other herbal powders.
- Concentrated granule extracts: Spray-dried aqueous extracts standardized to a fixed ratio (e.g., 5:1 concentration).
- Decoctions and infusions: Water-based preparations boiled or cold-infused from the fresh or dried rhizome.
- Cold infusions: In Ayurvedic practice, in conditions of burning urination and scanty urination, the cold infusion of the rhizome of Scirpus grossus is given in a dose of 30–40 ml.
- Topical pastes: Paste of Kaseruka, srngataká, and lotus tuber has been given with boiled milk for reproductive applications.
3. Traditional and Historical Use
Traditional Chinese Medicine (TCM)
Scirpus yagara Ohwi is a perennial aquatic plant whose dry tubers have long been used as the Traditional Chinese Medicine "Sanleng" for the treatment of postpartum abdominal pain, hyperemesis gravidarum, amenorrhea, dyspepsia, and several inflammatory-related diseases.
According to the principles of traditional Chinese medicine, Scirpus is described as neutral and bitter in nature, and is associated with the Spleen and Liver meridians. In TCM, San Leng belongs to the category of "Herbs that invigorate the Blood." These herbs are used to stimulate blood flow, to help circulation in cardiovascular conditions or menstrual irregularities, and to treat acute pains caused by blood stagnation. They can also be used to treat blood stagnation when it causes certain tumors, cysts, and hardened clots.
Scirpus is traditionally said to stimulate menstrual flow and promote the production of milk. It is also said to invigorate the blood, reduce pain following childbirth, and treat abdominal masses.
In the Chinese herbal tradition, Scirpus maritimus is used in the treatment of amenorrhoea, dysmenorrhoea, abdominal pain or tumors for post-partum females, abdominal distension, and indigestion.
The rhizome of Scirpus fluviatilis (river bulrush) is used as an emmenagogue, galactogogue, and antispasmodic in Japan and China.
The tuberous roots of Scirpus yagara have been used in traditional Chinese medicine for the treatment of hyperemesis gravidarum, postpartum abdominal pain, dyspepsia, and amenorrhea.
Ayurvedic and South Asian Traditions
Kasheruka – Scirpus grossus – is an Ayurvedic herb used for the treatment of diarrhea, thirst, nausea, scanty micturition, jaundice, improving sperm count, and weakness of the cardiac muscles.
The traditional Ayurvedic description of Kaseru characterizes it as: Sheeta (coolant), Madhura (sweet), Tuvara (astringent), Guru (heavy to digest), Grahi (absorbent, useful in diarrhea and IBS), Shukrakara (increases semen and sperm), and Stanyakara (promotes lactation). It is indicated in Raktapitta (bleeding disorders such as nasal bleeding, heavy periods), Daha (burning sensation), Nayanamaya (eye disorders), and Shrama (tiredness and fatigue).
The Ayurvedic Pharmacopoeia of India recommends the powder of the rhizome for promoting spermatogenesis and development of the breast. Tonic properties of Kaseru were used for promoting spermatogenesis and lactation. Flowers were prescribed for jaundice, while the tuber, pounded with rose-water, was used for vomiting, diarrhoea, burning sensation, and eruptions.
In Charak Samhita and Ashtanga Hridaya, tubers are mentioned under Ahar Varga (food groups), and Acharya Sushrut discussed them specifically in the Kanda Varga (group of tuberous vegetables).
In Ayurvedic medicine, the plant is esteemed for its cooling, diuretic, and digestive properties. The plant's rhizomes are traditionally used to treat various ailments, including gastrointestinal disorders and urinary tract issues.
Regional Indian Folk Medicine
Though not as celebrated as turmeric or ashwagandha in classical Ayurvedic texts, local healers in Kerala and West Bengal recorded use of Scirpus articulatus in region-specific manuscripts from the 16th–18th centuries. In the commentaries of the Sharangadhara Samhita, scribes mention a reed-like remedy used for urological complaints — likely a reference to Scirpus articulatus.
In northern India's folk medicine, rhizome decoctions were prepared during monsoon season to flush out excess water from joints. By the 19th century, British colonial botanists had documented the plant under its Latin name, noting its diuretic and mild astringent properties.
European Folk and Herbal Traditions
The roots of Scirpus lacustris are noted as astringent and diuretic. They were formerly employed medicinally but have fallen into disuse. Historical European herbalists used the species primarily as a foodstuff and fiber source rather than as a primary medicinal agent, though astringent and diuretic properties were recognized.
North American Indigenous Use
There are a variety of species of bulrushes (Scirpus sp.) in the Americas, all of which grow in moist environments and can be used as wild and nutritional additions to the human diet. Bulrushes are erect perennial, grass-like plants that can grow up to 3 meters tall. The rhizomes (or roots) produce edible tubers.
For Indigenous peoples, tule (Scirpus/Schoenoplectus acutus) has been a valuable resource for thousands of years. The plant has been traditionally harvested to make sleeping mats, baskets, cordage, and canoes. It has also been used to construct walls for homes and has served as a food source.
In North America their culms have been used, mostly historically, for making mats, baskets, chair seats, houses, boats, and other objects.
4. Key Constituents and Active Compounds
Overview of Phytochemical Classes
Previous studies conducted on Scirpus yagara have revealed an abundant number of secondary metabolites, including trans-stilbenoids, triterpenoids, flavonoids, and phenolic acids.
Phytochemical investigations of dichloromethane and methanol extracts of roots and rhizomes of Scirpoides holoschoenus afforded 21 stilbenes, six flavonoids, six ferulic acid derivatives, and four diterpenes. Among these constituents, six stilbenes, one flavonoid, one diterpene, and two ferulic acid derivatives represent previously unreported natural products.
Stilbenes: Scirpusin A and Scirpusin B
Two new hydroxystilbene dimers, named scirpusin A and scirpusin B, were isolated from the rhizoma of Scirpus fluviatilis (Torr.) A. Gray (Cyperaceae), together with two known hydroxystilbenes — resveratrol and 3,3',4,5'-tetrahydroxystilbene — and four known triterpenes: betulin, lupeol, betulinaldehyde, and betulinic acid.
Scirpusins A and B are abundant stilbene dimers in Scirpus and Cyperus species. Scirpusin A is the heterodimer of trans-resveratrol and piceatannol, while scirpusin B is formed through the connection of two resveratrol units.
Scirpusins are dimerized stilbenes; Scirpusin A is a dimerized resveratrol first isolated from the rhizome of Scirpus fluviatilis in 1978, along with resveratrol and 3,3',4,5'-tetrahydroxystilbene.
Sparstolonin B (SsnB)
Sparstolonin B (SsnB) is an isocoumarin compound isolated from the tubers of both Sparganium stoloniferum and Scirpus yagara. SsnB, derived from the tubers of Scirpus yagara, is a TLR2 and TLR4 antagonist and has exhibited multiple activities including anti-inflammatory, anti-cancer, anti-obesity, and anti-hepatitis effects.
Prenylated Stilbenes (from S. holoschoenus)
Separation of the extract of the tubers of Scirpus holoschoenus L. (family Cyperaceae) afforded 2-prenyl-3,5,4'-trimethoxystilbene, 2-prenyl-3-hydroxy-5,4'-dimethoxystilbene, 2-prenyl-3,4'-dihydroxy-5-methoxy-stilbene, and 3,5,4'-trimethoxystilbene, in addition to a new acetophenone derivative.
Phenolic Acids and Other Constituents
Only a few species of the genus Scirpus have been investigated for their chemical constituents. Derivatives of benzaldehyde, hydroxybenzoic acid, and cinnamic acid were isolated from the rhizomes of S. lacustris. Caffeic and coumaric acids were identified from S. wichurai. Ferulic acid has additionally been identified in S. yagara tubers.
Flavonoids and Saponins
Phytochemical studies on Scirpus articulatus have identified saponins (contributing to diuretic and expectorant effects by modulating renal tubular transport), flavonoids such as quercetin derivatives (providing antioxidant and mild anti-inflammatory actions), and tannins (exhibiting astringent and antimicrobial activity).
The root of Scirpus grossus is considered sweet, cooling, laxative, tonic to the liver, astringent, antidiarrheal, and antiemetic. Studies have shown antidiabetic, antipyretic, analgesic, and antihyperlipidemic properties.
Nutritional Components
Tuberous vegetables of the Cyperaceae, including Scirpus rhizomes, are rich in essential dietary components such as carbohydrates, proteins, fats, vitamins, and dietary fibres. In addition, they contain vitamins, minerals, trace elements, and biologically active molecules that function as antioxidants, phytoestrogens, and anti-inflammatory agents.
5. Established Mechanisms of Action
TLR2/TLR4 Antagonism (Sparstolonin B)
SsnB has been shown to block the Toll-like receptor (TLR) 2- and TLR4-triggered inflammatory signaling in macrophages by inhibiting the recruitment of MyD88 to the TIR domains of TLR2 and TLR4. This mechanism represents one of the most well-characterized pharmacological actions identified from Scirpus-derived compounds.
Suppression of NF-κB and STAT-1 Pathways
SsnB has been shown to upregulate HO-1 production, inhibit luciferase-NF-κB interaction, and lower COX-2/PGE2 and iNOS/NO, thereby leading to the reduction of STAT-1 phosphorylation. Moreover, SsnB enhanced the nuclear translocation of Nrf2 and elevated the binding activity between Nrf2 and antioxidant response elements (AREs).
Inhibition of Pro-inflammatory Cytokines
The anti-inflammatory effects of compounds from Scirpus yagara tubers against inflammatory cytokine production were evaluated in lipopolysaccharide- or Pam3csk4-stimulated macrophage RAW264.7 cells using ELISA. These compounds significantly inhibited tumor necrosis factor (TNF)-α and interleukin (IL)-6 productions in RAW264.7 cells, with IC50 values less than 20 μM.
Inhibition of p38 and ERK1/2 Signaling
SsnB has been shown to block p38 and ERK1/2 signaling pathways in LPS-induced cells. Silencing of p38 and ERK1/2 signaling significantly abated LPS-induced migration and invasion of B16 melanoma cells.
Pro-apoptotic and Anti-proliferative Activity
SsnB lowers cellular levels of glutathione (GSH) and increases generation of reactive oxygen species, activating the cleavage of caspase-3. Co-incubation with a GSH precursor, N-acetylcysteine, along with SsnB attenuates the inhibitory effects of SsnB and increases neuroblastoma cell viability, demonstrating that SsnB-induced ROS generation promotes apoptotic cell death.
Anti-angiogenic Effects
SsnB dose-dependently attenuated LPS-induced expression of interleukin (IL)-1β and monocyte chemoattractant protein-1 both at the transcription and translation levels in human umbilical vein endothelial cells (HUVECs). LPS-induced endothelial cell adhesion molecules, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) expressions were also reduced by treatment with SsnB.
Antioxidant Activity
As chemical constituents of Scirpus yagara, several trans-stilbenoids, triterpenoids, and flavonoids have been reported. These stilbenoids have attracted attention in relation to their wide range of activities, including antioxidant, antitumor, anti-inflammatory, antibacterial, anti-virus, and neuroprotective effects.
6. Scientific Evidence by Area of Use
6.1 Anti-inflammatory Activity
Evidence level: Preclinical (in vitro and animal models); no human clinical trials identified.
Although Scirpus yagara is known to have anti-inflammatory activities, its mechanism of action on LPS-induced inflammation had not been fully identified. One study investigated the anti-inflammatory activity of the active fraction (AF) from the tuber of Scirpus yagara both in vitro and in vivo, using RAW264.7 macrophages incubated with LPS in the absence or presence of AF (0, 10, 50, and 100 µg/ml); the secretions of TNF-α and IL-6 were determined by ELISA.
In experiments with an LPS-injected animal model, SsnB remarkably decreased iNOS expression in the pulmonary biostructure and TNF-α level in bronchoalveolar lavage fluid (BALF). These results demonstrate that SsnB exhibits inflammation-ameliorative activity by controlling iNOS through inhibition of both NF-κB expression and p-STAT-1.
Co-incubation with SsnB attenuated THP-1 monocyte adhesion to LPS-activated HUVECs. Furthermore, SsnB efficiently suppressed LPS-induced phosphorylation of Erk1/2 and Akt in HUVECs. These findings show that SsnB can suppress endothelial cell inflammation, suggesting that SsnB might be suitable for development as a therapeutic agent for inflammatory cardiovascular disease.
All anti-inflammatory research identified is preclinical. No randomized controlled trials or other human clinical studies of Scirpus preparations for inflammatory conditions were identified in the peer-reviewed literature.
6.2 Anticancer / Antitumor Research
Evidence level: Preclinical only (in vitro cell lines and mouse models); no human clinical trials.
Animal studies have found that Scirpus can inhibit the growth of cancerous tumors in mice, but these tests have yet to be conducted on humans.
One study reported a novel use of SsnB in mitigating TLR ligand-induced melanoma metastasis by inhibition of p38 and ERK1/2 pathways. In an experimental hepatic metastasis mouse model, SsnB repressed LPS-stimulated metastatic nodule formation along with liver weight, and significantly suppressed LPS-activated increases in levels of TNF-α and IL-6 in livers.
Researchers examined the anticancer activity of SsnB (8,5'-dihydroxy-4-phenyl-5,2'-oxidoisocoumarin) using neuroblastoma cell lines of different genetics. SsnB was isolated from an aquatic Chinese herb, and the tubers have been used in traditional Chinese medicine for the treatment of several inflammatory diseases and cancers. At 10 µM concentration, SsnB significantly inhibited the growth of both N-myc amplified (SK-N-BE(2), NGP, and IMR-32 cells) and N-myc non-amplified (SH-SY5Y and SKNF-1 cells) neuroblastoma cells.
The monoprenylated flavonoid sophoraflavanone B and all isolated stilbene oligomers — including trans-scirpusin B, scirpusin A, cassigarol E, cyperusphenol B, cyperusphenol D, passiflorinol A, cyperusphenol A, and mesocyperusphenol A — showed strong inhibitory activities on spore germination of two Botrytis cinerea strains.
Isolated stilbenoids were evaluated for their antiproliferative activity employing the Jurkat cell line (human T-cell leukemia cells), with estimated IC50 potencies reported for the different compounds.
The entirety of available anticancer evidence for Scirpus-derived compounds is limited to in vitro and rodent-model studies. The evidence does not support drawing conclusions about efficacy in human cancer.
6.3 Antioxidant Activity
Evidence level: Preclinical (in vitro); no human studies identified.
A total of 459 natural stilbene compounds have been identified from 45 plant families and 196 plant species. Pharmacological studies show that stilbenes — including those isolated from Scirpus — have various activities including anticancer, antimicrobial, antioxidant, anti-inflammatory, anti-degenerative disease, anti-diabetic, neuroprotective, anti-aging, and cardioprotective effects.
Two stilbene dimers, scirpusin A and B, together with resveratrol, 3,3',4,5'-tetrahydroxystilbene, and triterpenoids, were isolated from the rhizomes of S. fluviatilis. From the tubers of the same species, four stilbene trimers have been isolated, one of which has been formulated as an antiallergic and anti-inflammatory agent.
All antioxidant data are from in vitro assay systems. No clinical trials evaluating antioxidant outcomes in humans with Scirpus preparations were identified.
6.4 Diuretic and Renal / Urinary Effects
Evidence level: Traditional use well-documented; modern evidence very limited and preclinical.
In Ayurvedic medicine, Scirpus species are esteemed for their cooling, diuretic, and digestive properties. In conditions of burning urination and scanty urination, the cold infusion of the rhizome of Scirpus grossus is given in a dose of 30–40 ml in Ayurvedic practice.
Modern research suggests saponins in Scirpus promote urine output by inhibiting sodium reabsorption, while flavonoids scavenge free radicals in inflamed joints or kidney tissues. These mechanistic proposals are based on general phytochemical knowledge rather than specific human trials.
No controlled clinical trials specifically evaluating the diuretic effects of Scirpus preparations in human subjects were identified in the peer-reviewed literature.
6.5 Reproductive and Hormonal Effects
Evidence level: Traditional use only; no controlled human studies identified.
In TCM, San Leng is considered to strongly break up blood stagnation, invigorate blood and qi, relieve pain, regulate menstruation, remove food stagnation, and promote lactation.
Tonic properties of Kaseru were used for promoting spermatogenesis and lactation in Ayurvedic tradition, though no controlled clinical studies were identified to validate this use.
6.6 Gastrointestinal Effects
Evidence level: Traditional use; limited preclinical data.
Scirpus grossus has been used internally to treat vomiting, diarrhoea, cholera, jaundice, seminal debility, fever, and urinary bladder conditions in South Asian traditional medicine.
Its inclusion in nutritional products is generally regarded as safe when used in customary amounts, and its fiber content may support digestive wellness.
6.7 Cardiovascular Effects
Evidence level: Preclinical in vitro; no clinical trials identified.
Findings from cell-based studies show that SsnB can suppress endothelial cell inflammation, suggesting that SsnB might be suitable for development as a therapeutic agent for inflammatory cardiovascular disease. These findings are preliminary and limited to in vitro models.
In Ayurvedic tradition, Scirpus grossus is described as one of the best cardiotonics, though this attribution is based on traditional characterization and not on controlled clinical evidence.
Overall Evidence Assessment
Despite the wide spectrum of use of Cyperaceae species, scientific evidence to validate the indications mentioned by traditional communities is lacking for most of them.
Comprehensive human clinical trials specifically evaluating the nutritional or therapeutic impact of Scirpus remain limited. The available body of evidence is almost entirely preclinical — comprising in vitro cell studies and animal models. It is not possible on the basis of current evidence to draw conclusions about efficacy, optimal dosing, or safety in human populations.
7. Body Systems and Health Areas Associated with Scirpus
- Digestive system: Traditionally used for diarrhea, nausea, vomiting, indigestion, dyspepsia, cholera, and food stagnation.
- Urinary system: Traditionally used as a diuretic; for scanty urination, edema, and urinary tract complaints.
- Female reproductive system: Traditionally used for amenorrhea, dysmenorrhea, postpartum abdominal pain, abdominal masses, and to stimulate lactation.
- Male reproductive system: Traditionally used to promote spermatogenesis.
- Cardiovascular system: Described in Ayurveda as cardiotonic; preclinical research suggests anti-inflammatory effects on vascular endothelium.
- Immune and inflammatory pathways: Preclinical research on SsnB and stilbene compounds demonstrates inhibition of TLR-mediated inflammatory cascades and suppression of TNF-α, IL-6, and IL-1β.
- Oncology (research context only): In vitro and animal studies have investigated antiproliferative and anti-metastatic properties; no clinical evidence exists.
- Eye health: In conditions of conjunctivitis, the cold infusion prepared from the rhizome of Kasheruka (S. grossus) has been used as eye drops in Ayurvedic practice.
8. Dosage Forms and Dosages Reported in Sources
The following dosages are reported in traditional or practitioner-oriented sources; they are not derived from controlled clinical trials and reflect historical or TCM practice guidelines only:
- TCM decoction (dried rhizome): The recommended dosage of Scirpus in TCM is 3–9 grams, placed in boiling water and drunk as a decoction.
- Ayurvedic cold infusion (rhizome, S. grossus): In conditions of burning and scanty urination, the cold infusion of the rhizome of Scirpus grossus is given in a dose of 30–40 ml.
- Concentrated granule extract (commercial, 5:1): Formulated products have been sold with instructions to take 0.5 g per serving, one to two times daily, equivalent to approximately 2.5 g dried rhizome per dose.
- Research dosing (SsnB, in vitro / animal): In cell-based studies, SsnB at 10 µM concentration significantly inhibited neuroblastoma cell growth; in vascular studies, 100 µM SsnB decreased normalized branching number in endothelial tube formation assays. These are experimental concentrations in laboratory settings, not human doses.
No standardized human clinical dosage has been established for any preparation of Scirpus through controlled trials.
9. Safety Considerations and Known Interactions
Contraindications Documented in Traditional Practice
Because Scirpus stimulates menstrual flow, it should not be used by women who are pregnant, or during periods of heavy menstruation.
San Leng precautions documented in TCM practice state that it should not be used if pregnant or nursing, and should not be used in cases of excessive bleeding.
Drug Interactions
At this time, there are no known drug interactions with Scirpus reported in the practitioner literature. This absence of documented interactions reflects the extremely limited formal pharmacokinetic and pharmacodynamic study of Scirpus preparations in humans, rather than confirmed safety.
Apoptosis-Inducing Mechanism (Preclinical Safety Signal)
SsnB has been shown to lower the cellular level of glutathione (GSH) and increase generation of reactive oxygen species, activating the cleavage of caspase-3. While this mechanism is under investigation as a potential anticancer mechanism, it also implies that concentrated SsnB preparations could have pro-oxidant effects at sufficient doses — a consideration that has not yet been evaluated in human safety studies.
General Evidence Gap
Comprehensive human clinical trials specifically evaluating the nutritional or therapeutic impact of Scirpus remain limited. Its inclusion in nutritional products is generally regarded as safe when used in customary amounts, and its fiber content may support digestive wellness.
As interest in functional foods grows, Scirpus represents a promising, yet underexplored, botanical. Ongoing and future research will be crucial to substantiate its efficacy and unravel the mechanisms behind its traditional uses.
Formal toxicology studies, pharmacokinetic data in humans, and systematic safety evaluations of Scirpus preparations have not been identified in the peer-reviewed literature. No monograph from the WHO, ESCOP, German Commission E, EMA, or EFSA specifically covering Scirpus species as a medicinal supplement ingredient was identified.
References
Go back